Vesicare
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Overactive Bladder
Conditions
Overactive Bladder
Trial Timeline
Jun 1, 2010 → Apr 1, 2011
NCT ID
NCT01489709About Vesicare
Vesicare is a pre-clinical stage product being developed by Astellas Pharma for Overactive Bladder. The current trial status is completed. This product is registered under clinical trial identifier NCT01489709. Target conditions include Overactive Bladder.
What happened to similar drugs?
10 of 20 similar drugs in Overactive Bladder were approved
Approved (10) Terminated (1) Active (9)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01215721 | Pre-clinical | Completed |
| NCT01489709 | Pre-clinical | Completed |
| NCT00581061 | Pre-clinical | Terminated |
Competing Products
20 competing products in Overactive Bladder